HDAC inhibitors decrease mogamulizumab efficacy with downregulation of CCR4 in T-cell lymphoma

被引：0
|
作者：
Kitadate, Akihiro [1 ]
Ikeda, Sho [1 ]
Abe, Fumito [1 ]
Teshima, Kazuaki [1 ]
Takahashi, Naoto [1 ]
Matsue, Kosei [2 ]
Tagawa, Hiroyuki [1 ]
机构：
[1] Akita Univ, Sch Med, Dept Hematol Nephrol & Rheumatol, Akita 010, Japan
[2] Div Hematol, Akita 010, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
Malignant lymphoma; HDAC inhibitor;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E-2025
引用
收藏
页码：506 / 506
页数：1
相关论文
共 50 条
  • [31] Drug Development of Mogamulizumab, anti-CCR4 antibody, for Adult T-cell Leukemia-Lymphoma
    Ishii, Toshihiko
    Takahashi, Takeshi
    Akinaga, Shiro
    Ishida, Takashi
    Matsushima, Kouji
    Ueda, Ryuzo
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 121 : 48P - 48P
  • [32] Loss of tumor cell CCR4 expression upon leukemic change in adult T-cell leukemia/lymphoma
    Sugita, Kazunari
    Shimauchi, Takatoshi
    Kabashima, Rieko
    Nakashima, Daiki
    Hino, Ryosuke
    Kabashima, Kenji
    Nakamura, Motonobu
    Tokura, Yoshiki
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 61 (01) : 163 - 164
  • [33] Frequent gain-of-function CCR4 mutations in adult T-cell leukemia/lymphoma (ATLL)
    Nakagawa, Masao
    Schmitz, Roland
    Xiao, Wenming
    Goldman, Carolyn K.
    Xu, Weihong
    Yang, Yandan
    Yu, Xin
    Waldmann, Thomas A.
    Staudt, Louis M.
    CANCER RESEARCH, 2015, 75
  • [34] Current Status of HDAC Inhibitors in Cutaneous T-cell Lymphoma
    Lopez, Adriana T.
    Bates, Susan
    Geskin, Larisa
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2018, 19 (06) : 805 - 819
  • [35] Current Status of HDAC Inhibitors in Cutaneous T-cell Lymphoma
    Adriana T. Lopez
    Susan Bates
    Larisa Geskin
    American Journal of Clinical Dermatology, 2018, 19 : 805 - 819
  • [36] Cutaneous T-Cell Lymphoma Optimizing care in patients receiving anti-CCR4 monoclonal antibody mogamulizumab
    Tawa, Marianne
    Kopp, Erin
    McCann, Sue
    Cantrell, Wandy
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2019, 23 (04) : E73 - E80
  • [37] A Multicenter Retrospective Study of Mogamulizumab Efficacy in Adult T-Cell Leukemia/Lymphoma
    Iyama, Satoshi
    Sato, Tsutomu
    Ohnishi, Hirofumi
    Kanisawa, Yuji
    Ohta, Shuichi
    Kondo, Takeshi
    Mori, Akio
    Tsutsumi, Yutaka
    Kuroda, Hiroyuki
    Kakinoki, Yasutaka
    Yamamoto, Satoshi
    Takahashi, Tohru
    Shindo, Motohiro
    Torimoto, Yoshihiro
    Sato, Kazuya
    Iwasaki, Hiroshi
    Haseyama, Yoshihito
    Kohda, Kyuhei
    Nagamachi, Yasuhiro
    Hirayama, Yasuo
    Sakai, Hajime
    Hirata, Yasuji
    Fukuhara, Takashi
    Ikeda, Hiroshi
    Kobune, Masayoshi
    Kato, Junji
    Kurosawa, Mitsutoshi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : 23 - 30
  • [38] CCR4: Chemokine receptor as a novel molecular target for immunotherapy in adult T-cell leukemia/lymphoma (ATLL).
    Ishida, T
    Iida, S
    Akatsuka, Y
    Miyazaki, M
    Sanda, T
    Inagaki, A
    Kayukawa, S
    Uranishi, M
    Komatsu, H
    Atsushi, W
    Shitara, K
    Akinaga, S
    Nakamura, S
    Inagaki, H
    Utsunomiya, A
    Ueda, R
    BLOOD, 2003, 102 (11) : 900A - 900A
  • [39] In vitro effect of Jak and HDAC inhibitors in cutaneous T-cell lymphoma
    Karagianni, F.
    Saraki, K.
    Papadaki, M.
    Mpakou, V.
    Piperi, C.
    Pappa, V.
    Papadavid, E.
    EUROPEAN JOURNAL OF CANCER, 2019, 119 : S4 - S4
  • [40] C1014T single nucleotide polymorphism of CCR4 is frequent in caucasian patients with cutaneous T-cell lymphoma
    Ni, X.
    Hu, C.
    Amador, A.
    Xue, Y.
    Duvic, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S27 - S27
12345